• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多机构回顾性研究:评估上颌窦鳞状细胞癌眼眶侵犯患者的眼功能保留率

Multi-institutional retrospective study for the evaluation of ocular function-preservation rates in maxillary sinus squamous cell carcinomas with orbital invasion.

作者信息

Sakashita Tomohiro, Hayashi Ryuichi, Homma Akihiro, Matsuura Kazuto, Kato Kengo, Kawabata Kazuyoshi, Monden Nobuya, Hasegawa Yasuhisa, Onitsuka Tetsuro, Fujimoto Yasushi, Iwae Shigemichi, Okami Kenji, Matsuzuka Takashi, Yoshino Kunitoshi, Fujii Masato

机构信息

Department of Otolaryngology-Head and Neck Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

出版信息

Head Neck. 2015 Apr;37(4):537-42. doi: 10.1002/hed.23639. Epub 2014 Apr 9.

DOI:10.1002/hed.23639
PMID:24715544
Abstract

BACKGROUND

The purpose of this retrospective analysis was to evaluate ocular function and survival rates among treatment modalities in patients with maxillary sinus cancer with orbital invasion.

METHODS

Eighty-seven patients were classified according to the main treatment modality. Ocular function preservation rates and survival rates were evaluated for each therapeutic modality.

RESULTS

The 5-year overall survival rate for the en bloc resection, conservative surgery, superselective intra-arterial chemotherapy, and radiotherapy (RADPLAT), intravenous chemoradiotherapy (IV-CRT) was 70%, 35%, 49%, and 31%, respectively. The ocular function preservation rate for each group was 15%, 27%, 30%, and 17%, respectively. In the en bloc resection group, there was no significant difference in the 5-year overall survival rate between patients with orbital exenteration and those without orbital exenteration (72% vs 71%; p = .9321).

CONCLUSION

The en bloc resection group showed a favorable survival rate but a low preservation rate. Preservation of orbital contents did not reduce the survival rate.

摘要

背景

本回顾性分析的目的是评估上颌窦癌侵犯眼眶患者不同治疗方式下的眼部功能和生存率。

方法

87例患者根据主要治疗方式进行分类。对每种治疗方式的眼部功能保留率和生存率进行评估。

结果

整块切除、保守手术、超选择性动脉内化疗和放疗(RADPLAT)、静脉化疗放疗(IV-CRT)的5年总生存率分别为70%、35%、49%和31%。每组的眼部功能保留率分别为15%、27%、30%和17%。在整块切除组中,行眼眶内容物剜除术的患者与未行眼眶内容物剜除术的患者5年总生存率无显著差异(72%对71%;p = 0.9321)。

结论

整块切除组生存率良好但保留率低。保留眼眶内容物并未降低生存率。

相似文献

1
Multi-institutional retrospective study for the evaluation of ocular function-preservation rates in maxillary sinus squamous cell carcinomas with orbital invasion.多机构回顾性研究:评估上颌窦鳞状细胞癌眼眶侵犯患者的眼功能保留率
Head Neck. 2015 Apr;37(4):537-42. doi: 10.1002/hed.23639. Epub 2014 Apr 9.
2
Management of the orbital contents in radical surgery for squamous cell carcinoma of the maxillary sinus.上颌窦鳞状细胞癌根治术中眼眶内容物的处理
Chin Med J (Engl). 1995 Feb;108(2):123-5.
3
Results of orbital preservation for advanced malignant maxillary sinus tumors.晚期恶性上颌窦肿瘤眼眶保留的结果。
Laryngoscope. 2003 Jun;113(6):1064-9. doi: 10.1097/00005537-200306000-00028.
4
[Management in squamous cell carcinoma of maxillary sinus with orbital invasion].[上颌窦鳞状细胞癌伴眼眶侵犯的治疗]
Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006 Oct;20(20):937-8.
5
Multidisciplinary therapy consisting of minimally invasive resection, irradiation, and intra-arterial infusion of 5-fluorouracil for maxillary sinus carcinomas.采用微创切除术、放疗和经动脉内输注 5-氟尿嘧啶治疗上颌窦癌的多学科治疗方法。
Head Neck. 2013 Jun;35(6):772-8. doi: 10.1002/hed.23030. Epub 2012 Jun 23.
6
Orbital preservation in maxillectomy.上颌骨切除术术中的眶部保留
Otolaryngol Head Neck Surg. 1993 Jul;109(1):111-5. doi: 10.1177/019459989310900120.
7
Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.随机对照试验比较手术和辅助放疗与同期放化疗治疗晚期局部非转移性头颈部鳞状细胞癌患者:10 年更新和亚组分析。
Cancer. 2015 May 15;121(10):1599-607. doi: 10.1002/cncr.29251. Epub 2015 Jan 29.
8
Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.对上颌窦持续性或复发性癌症患者在超选择性动脉内输注顺铂并同步放疗后的挽救手术。
Br J Oral Maxillofac Surg. 2014 Apr;52(4):323-8. doi: 10.1016/j.bjoms.2014.01.018. Epub 2014 Feb 26.
9
The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.未行预防性颈部放疗的N0期上颌窦鳞状细胞癌经超选择性动脉内放化疗后颈部迟发性复发的发生率
Eur Arch Otorhinolaryngol. 2014 Oct;271(10):2767-70. doi: 10.1007/s00405-013-2806-4. Epub 2013 Nov 9.
10
Post-treatment magnetic resonance imaging predicts outcomes of maxillary sinus cancer treatment using super-selective intra-arterial infusion of high-dose cisplatin with concomitant radiotherapy (RADPLAT).经动脉内超选择性高剂量顺铂联合放疗(RADPLAT)治疗上颌窦癌的治疗后磁共振成像预测结果。
Auris Nasus Larynx. 2024 Aug;51(4):631-635. doi: 10.1016/j.anl.2024.03.007. Epub 2024 Apr 15.

引用本文的文献

1
Locally advanced maxillary sinus cancer fed from the internal carotid artery.由颈内动脉供血的局部晚期上颌窦癌。
Eur Arch Otorhinolaryngol. 2025 Mar 28. doi: 10.1007/s00405-025-09343-7.
2
Evidence Based Recommendations in Sinonasal Tumors Involving Orbit: Preservation or Exenteration? An IHNSG Guidelines.涉及眼眶的鼻窦肿瘤的循证建议:保留还是眶内容剜除术?国际鼻窦外科学会指南。
Adv Ther. 2025 Mar;42(3):1312-1339. doi: 10.1007/s12325-025-03113-x. Epub 2025 Feb 6.
3
A case of bleeding from maxillary carcinoma embolized from the maxillary and ophthalmic arteries.
1例上颌癌经上颌动脉和眼动脉栓塞后出血的病例。
CVIR Endovasc. 2020 Oct 2;3(1):74. doi: 10.1186/s42155-020-00167-6.
4
Considerations in Orbital Reconstruction for the Oncologic Surgeon: Critical versus Optimal Objectives.肿瘤外科医生眼眶重建的考量:关键目标与最佳目标
Indian J Plast Surg. 2019 May;52(2):231-237. doi: 10.1055/s-0039-1696624. Epub 2019 Aug 29.
5
Complications in Salvage Surgery for Nasal and Paranasal Malignant Tumors Involving the Skull Base.累及颅底的鼻腔及鼻窦恶性肿瘤挽救性手术的并发症
J Neurol Surg B Skull Base. 2018 Jun;79(3):224-228. doi: 10.1055/s-0037-1606382. Epub 2017 Sep 14.
6
Organ preservation with neoadjuvant chemoradiation in patients with orbit invasive sinonasal cancer otherwise requiring exenteration.对于原本需要进行眼眶内容剜除术的眼眶侵袭性鼻窦癌患者,采用新辅助放化疗进行器官保留。
Radiat Oncol J. 2016 Sep;34(3):209-215. doi: 10.3857/roj.2016.01739. Epub 2016 Sep 5.